KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentChange in Working CapitalChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Capital Expenditures (2017 - 2025)

Aurora Cannabis has reported Capital Expenditures over the past 9 years, most recently at $23.3 million for Q1 2025.

  • Quarterly Capital Expenditures rose 11.68% to $23.3 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $12.7 million through Mar 2025, down 12.91% year-over-year, with the annual reading at $13.1 million for FY2025, 5.21% up from the prior year.
  • Capital Expenditures was $23.3 million for Q1 2025 at Aurora Cannabis, up from -$3.5 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $77.2 million in Q2 2021 and troughed at -$9.6 million in Q1 2021.
  • The 5-year median for Capital Expenditures is -$3.4 million (2022), against an average of $4.6 million.
  • The largest YoY upside for Capital Expenditures was 87.76% in 2022 against a maximum downside of 105.99% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at -$8.9 million in 2021, then skyrocketed by 87.76% to -$1.1 million in 2022, then plummeted by 86.39% to -$2.0 million in 2023, then plummeted by 70.55% to -$3.5 million in 2024, then skyrocketed by 769.6% to $23.3 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Capital Expenditures are $23.3 million (Q1 2025), -$3.5 million (Q4 2024), and -$3.3 million (Q3 2024).